<VariationArchive VariationID="1070201" VariationName="NM_003742.4(ABCB11):c.2319dup (p.Phe774fs)" VariationType="Duplication" Accession="VCV001070201" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-19" DateCreated="2021-05-10" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1059089" VariationID="1070201">
      <GeneList>
        <Gene Symbol="ABCB11" FullName="ATP binding cassette subfamily B member 11" GeneID="8647" HGNC_ID="HGNC:42" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="168915390" stop="169031324" display_start="168915390" display_stop="169031324" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_003315909.1" start="107408" stop="123061" display_start="107408" display_stop="123061" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="169779448" stop="169887832" display_start="169779448" display_stop="169887832" Strand="-" />
          </Location>
          <OMIM>603201</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003742.4(ABCB11):c.2319dup (p.Phe774fs)</Name>
      <CanonicalSPDI>NC_000002.12:168957987:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="168957987" stop="168957988" display_start="168957987" display_stop="168957988" variantLength="1" positionVCF="168957987" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="169814497" stop="169814498" display_start="169814497" display_stop="169814498" variantLength="1" positionVCF="169814497" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>F774fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.169814499dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.169814499dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.168957989dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.168957989dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007374.2" sequenceAccession="NG_007374" sequenceVersion="2" change="g.78409dup">
            <Expression>NG_007374.2:g.78409dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003742.4" sequenceAccession="NM_003742" sequenceVersion="4" change="c.2319dup" MANESelect="true">
            <Expression>NM_003742.4:c.2319dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003733.2" sequenceAccession="NP_003733" sequenceVersion="2" change="p.Phe774fs">
            <Expression>NP_003733.2:p.Phe774fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1199" sequenceAccession="LRG_1199">
            <Expression>LRG_1199:g.78409dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1199t1" sequenceAccession="LRG_1199t1">
            <Expression>LRG_1199t1:c.2319dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1199p1" sequenceAccession="LRG_1199p1" change="p.Phe774fs">
            <Expression>LRG_1199p1:p.Phe774fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003742.2" sequenceAccession="NM_003742" sequenceVersion="2" change="c.2319dupC">
            <Expression>NM_003742.2:c.2319dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1692870573" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003742.4(ABCB11):c.2319dup (p.Phe774fs) AND not provided" Accession="RCV001382266" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003742.4(ABCB11):c.2319dup (p.Phe774fs) AND multiple conditions" Accession="RCV002493923" Version="1">
        <ClassifiedConditionList TraitSetID="9065">
          <ClassifiedCondition DB="MedGen" ID="C2608083">Benign recurrent intrahepatic cholestasis type 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3489789">Progressive familial intrahepatic cholestasis type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-28" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003742.4(ABCB11):c.2319dup (p.Phe774fs) AND Benign recurrent intrahepatic cholestasis type 2" Accession="RCV003462983" Version="1">
        <ClassifiedConditionList TraitSetID="6596">
          <ClassifiedCondition DB="MedGen" ID="C2608083">Benign recurrent intrahepatic cholestasis type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003742.4(ABCB11):c.2319dup (p.Phe774fs) AND ABCB11-related disorder" Accession="RCV003953697" Version="1">
        <ClassifiedConditionList TraitSetID="89173">
          <ClassifiedCondition>ABCB11-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-21" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2021-05-10" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18395098</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20232290</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34016879</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="89173" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69205" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ABCB11-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">ABCB11-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9065" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="794" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Benign recurrent intrahepatic cholestasis type 2</ElementValue>
                <XRef ID="MONDO:0011559" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Recurrent familial intrahepatic cholestasis 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BRIC2</ElementValue>
                <XRef Type="MIM" ID="605479" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of ATP8B1 deficiency ranges from severe through moderate to mild. Severe ATP8B1 deficiency is characterized by infantile-onset cholestasis that progresses to cirrhosis, hepatic failure, and early death. Although mild-to-moderate ATP8B1 deficiency initially was thought to involve intermittent symptomatic cholestasis with a lack of hepatic fibrosis, it is now known that hepatic fibrosis may be present early in the disease course. Furthermore, in some persons with ATP8B1 deficiency the clinical findings can span the phenotypic spectrum, shifting over time from the mild end of the spectrum (episodic cholestasis) to the severe end of the spectrum (persistent cholestasis). Sensorineural hearing loss (SNHL) is common across the phenotypic spectrum.</Attribute>
                <XRef ID="NBK1297" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10029" />
                <XRef ID="10029" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301474</ID>
                <ID Source="BookShelf">NBK1297</ID>
              </Citation>
              <XRef ID="65682" DB="Orphanet" />
              <XRef ID="99961" DB="Orphanet" />
              <XRef ID="C2608083" DB="MedGen" />
              <XRef ID="MONDO:0011559" DB="MONDO" />
              <XRef Type="MIM" ID="605479" DB="OMIM" />
            </Trait>
            <Trait ID="1429" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Progressive familial intrahepatic cholestasis type 2</ElementValue>
                <XRef ID="MONDO:0011156" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PFIC2</ElementValue>
                <XRef Type="MIM" ID="601847" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of ATP8B1 deficiency ranges from severe through moderate to mild. Severe ATP8B1 deficiency is characterized by infantile-onset cholestasis that progresses to cirrhosis, hepatic failure, and early death. Although mild-to-moderate ATP8B1 deficiency initially was thought to involve intermittent symptomatic cholestasis with a lack of hepatic fibrosis, it is now known that hepatic fibrosis may be present early in the disease course. Furthermore, in some persons with ATP8B1 deficiency the clinical findings can span the phenotypic spectrum, shifting over time from the mild end of the spectrum (episodic cholestasis) to the severe end of the spectrum (persistent cholestasis). Sensorineural hearing loss (SNHL) is common across the phenotypic spectrum.</Attribute>
                <XRef ID="NBK1297" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1288" />
                <XRef ID="1288" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301474</ID>
                <ID Source="BookShelf">NBK1297</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36108118</ID>
                <ID Source="BookShelf">NBK584020</ID>
              </Citation>
              <XRef ID="79304" DB="Orphanet" />
              <XRef ID="C3489789" DB="MedGen" />
              <XRef ID="MONDO:0011156" DB="MONDO" />
              <XRef Type="MIM" ID="601847" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6596" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="794" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Benign recurrent intrahepatic cholestasis type 2</ElementValue>
                <XRef ID="MONDO:0011559" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Recurrent familial intrahepatic cholestasis 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BRIC2</ElementValue>
                <XRef Type="MIM" ID="605479" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of ATP8B1 deficiency ranges from severe through moderate to mild. Severe ATP8B1 deficiency is characterized by infantile-onset cholestasis that progresses to cirrhosis, hepatic failure, and early death. Although mild-to-moderate ATP8B1 deficiency initially was thought to involve intermittent symptomatic cholestasis with a lack of hepatic fibrosis, it is now known that hepatic fibrosis may be present early in the disease course. Furthermore, in some persons with ATP8B1 deficiency the clinical findings can span the phenotypic spectrum, shifting over time from the mild end of the spectrum (episodic cholestasis) to the severe end of the spectrum (persistent cholestasis). Sensorineural hearing loss (SNHL) is common across the phenotypic spectrum.</Attribute>
                <XRef ID="NBK1297" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10029" />
                <XRef ID="10029" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301474</ID>
                <ID Source="BookShelf">NBK1297</ID>
              </Citation>
              <XRef ID="65682" DB="Orphanet" />
              <XRef ID="99961" DB="Orphanet" />
              <XRef ID="C2608083" DB="MedGen" />
              <XRef ID="MONDO:0011559" DB="MONDO" />
              <XRef Type="MIM" ID="605479" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5446912" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_003742.4:c.2319dup|OMIM:601847;605479" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002803877" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003742.4:c.2319dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601847" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605479" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7864158" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_003742.4:c.2319dup|OMIM:605479" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004217023" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003742.4:c.2319dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605479" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3106561" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="6863726|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001580947" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18395098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20232290</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34016879</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe774Leufs*14) in the ABCB11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCB11 are known to be pathogenic (PMID: 18395098, 20232290). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with cholestasis (PMID: 34016879). ClinVar contains an entry for this variant (Variation ID: 1070201). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCB11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.169814497_169814498insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8860284" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="33610950|ABCB11-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004776775" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The ABCB11 c.2319dupC variant is predicted to result in a frameshift and premature protein termination (p.Phe774Leufs*14). This variant was reported, along with a second presumptively causative variant, in an individual with intrahepatic cholestasis (SDC Table 3, Hertel et al 2021. PubMed ID: 34016879). This variant has not been reported in a large population database, indicating it is rare. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCB11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003742.2:c.2319dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ABCB11-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3106561" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7864158" TraitType="Disease" MappingType="XRef" MappingValue="605479" MappingRef="OMIM">
        <MedGen CUI="C2608083" Name="Benign recurrent intrahepatic cholestasis type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446912" TraitType="Disease" MappingType="XRef" MappingValue="605479" MappingRef="OMIM">
        <MedGen CUI="C2608083" Name="Benign recurrent intrahepatic cholestasis type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8860284" TraitType="Disease" MappingType="Name" MappingValue="ABCB11-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="ABCB11-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446912" TraitType="Disease" MappingType="XRef" MappingValue="601847" MappingRef="OMIM">
        <MedGen CUI="C3489789" Name="Progressive familial intrahepatic cholestasis type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

